Related Experiment Videos
Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia
N T Hertel1, F K Pedersen, C Heilmann
1University Clinic of Paediatrics, Department G, Rigshospitalet, Copenhagen, Denmark.
Abstract:
A 19-month-old boy with agammaglobulinaemia contracted a Coxsackie B3 virus infection which caused meningoencephalitis. His neurological status deteriorated over the following 4 years and he died aged 6 years. Treatment with gammaglobulin i.m. and IgG-Fab2 fragments i.v. was not effective. Enterovirus can cause life-threatening infections in immunodeficient patients.
Insights
Agammaglobulinaemia patients are susceptible to severe enterovirus infections. A young boy with this condition developed fatal meningoencephalitis from Coxsackie B3 virus, highlighting risks in immunodeficiency.
Area of Science:
- Virology
- Immunology
- Neurology
Background:
- Agammaglobulinaemia is a primary immunodeficiency characterized by a severe lack of immunoglobulins.
- Patients with agammaglobulinaemia are at increased risk for severe and recurrent infections.
- Enteroviruses, including Coxsackie B3 virus, are common pathogens with variable clinical manifestations.
Observation:
- A 19-month-old boy diagnosed with agammaglobulinaemia acquired a Coxsackie B3 virus infection.
- The infection led to the development of meningoencephalitis, a serious inflammation of the brain and its surrounding membranes.
- The patient experienced progressive neurological deterioration over four years, ultimately succumbing to the illness at age six.
Findings:
- Despite treatment with intramuscular gammaglobulin and intravenous IgG-Fab2 fragments, the patient's condition did not improve.
- This case underscores the potential for enteroviruses to cause life-threatening infections in individuals with compromised immune systems.
- The ineffectiveness of standard immunoglobulin therapies suggests challenges in managing severe enteroviral encephalitis in agammaglobulinaemia.
Implications:
- This case highlights the critical need for vigilance and potentially novel therapeutic strategies for enterovirus infections in immunodeficient populations.
- Understanding the pathogenesis of enteroviral meningoencephalitis in agammaglobulinaemia is crucial for improving patient outcomes.
- Further research into the management of severe viral infections in primary immunodeficiencies is warranted.